Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-Agent: * |
Title | Verismo Therapeutics: KIR-CAR T Cell Therapy for Solid |
Description | Paradigm-shifting CAR T-cell therapy for solid A paradigm-shifting technology featuring KIR-based CAR construct that has been proven to reduce T cell exhaustion & kill solid tumor models in in vivo |
Keywords | N/A |
WebSite | verismotherapeutics.com |
Host IP | 166.62.105.245 |
Location | United States |
Site | Rank |
US$3,745,646
Last updated: 2023-05-19 10:54:47
verismotherapeutics.com has Semrush global rank of 2,825,762. verismotherapeutics.com has an estimated worth of US$ 3,745,646, based on its estimated Ads revenue. verismotherapeutics.com receives approximately 432,190 unique visitors each day. Its web server is located in United States, with IP address 166.62.105.245. According to SiteAdvisor, verismotherapeutics.com is safe to visit. |
Purchase/Sale Value | US$3,745,646 |
Daily Ads Revenue | US$3,458 |
Monthly Ads Revenue | US$103,726 |
Yearly Ads Revenue | US$1,244,707 |
Daily Unique Visitors | 28,813 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
verismotherapeutics.com. 7199 | A | verismotherapeutics.com. 7199 | IP: 166.62.105.245 |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: dns1.p08.nsone.net. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: dns2.p08.nsone.net. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: dns3.p08.nsone.net. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: dns4.p08.nsone.net. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: ns01.squarespacedns.com. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: ns02.squarespacedns.com. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: ns03.squarespacedns.com. |
verismotherapeutics.com. 3600 | NS | verismotherapeutics.com. 3600 | NS Record: ns04.squarespacedns.com. |
verismotherapeutics.com. 14400 | MX | verismotherapeutics.com. 14400 | MX Record: 0 verismotherapeutics-com.mail.protection.outlook.com. |
verismotherapeutics.com. 14400 | TXT | verismotherapeutics.com. 14400 | TXT Record: MS=ms20743528 |
verismotherapeutics.com. 14400 | TXT | verismotherapeutics.com. 14400 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
verismotherapeutics.com. 14400 | TXT | verismotherapeutics.com. 14400 | TXT Record: 91v1m06j137fmhnrt5phk15r7l |
--> Science Team Pipeline Media Join Us Contact Science Team Pipeline Media Join Us Contact Paradigm-shifting CAR T-cell therapy for solid tumors Defining the next generation of CAR T-cell therapy Verismo Therapeutics is pioneering CAR T-cell therapy for the treatment of solid tumors. This paradigm-shifting technology features a unique KIR-CAR construct that has been proven to reduce T-cell exhaustion and kill solid tumor models in in vivo studies. The paradigm shift in CAR T-cell therapy Verismo’s paradigm-shifting generation 2.0 KIR-CAR platform: Features multi-chain immunoreceptor design Enables T-cells to remain effective long-term Excels in challenging solid tumor micro-environments Prior 1.X CAR T-cell therapies: Utilize the traditional single-chain CAR construct Fail to eliminate solid tumors Exhausts T-cells through constant single-chain stimulation CAR T History > The first KIR-CAR platform proven to be effective on solid tumors Verismo is pioneering the further |
HTTP/1.1 308 Permanent Redirect Content-Type: text/html; charset=utf-8 Location: https://verismotherapeutics.com/ Date: Thu, 29 Sep 2022 08:42:47 GMT HTTP/2 200 server: openresty date: Thu, 29 Sep 2022 08:42:43 GMT content-type: text/html; charset=UTF-8 content-length: 37010 accept-ranges: bytes age: 65722 content-security-policy: upgrade-insecure-requests strict-transport-security: max-age=300 vary: Accept-Encoding, User-Agent x-backend: local x-cache: cached x-cache-hit: HIT x-cacheable: YES:Forced x-cacheproxy-retries: 0/2 x-content-type-options: nosniff x-fawn-proc-count: 1,1,24 x-php-version: 8.0 x-xss-protection: 1; mode=block strict-transport-security: max-age=31536000; includeSubDomains |
Domain Name: VERISMOTHERAPEUTICS.COM Registry Domain ID: 2562346839_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.tucows.com Registrar URL: http://www.tucows.com Updated Date: 2022-09-12T18:29:08Z Creation Date: 2020-09-27T15:57:51Z Registry Expiry Date: 2023-09-27T15:57:51Z Registrar: Tucows Domains Inc. Registrar IANA ID: 69 Registrar Abuse Contact Email: domainabuse@tucows.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: DNS1.P08.NSONE.NET Name Server: DNS2.P08.NSONE.NET Name Server: DNS3.P08.NSONE.NET Name Server: DNS4.P08.NSONE.NET Name Server: NS01.SQUARESPACEDNS.COM Name Server: NS02.SQUARESPACEDNS.COM Name Server: NS03.SQUARESPACEDNS.COM Name Server: NS04.SQUARESPACEDNS.COM DNSSEC: unsigned >>> Last update of whois database: 2022-09-29T08:38:34Z <<< |